Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Wan

Showing results (1171-1180 of 1,448) with videos related to

Pageof 145
Sort By:
Circulation. Cardiovascular Imaging|September 11, 2019
Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary HypertensionKhodr Tello, Jun Wan, Antonia Dalmer, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|February 12, 2021
Long non-coding RNA PCA3 inhibits lipid accumulation and atherosclerosis through the miR-140-5p/RFX7/ABCA1 axisZhen-Wang Zhao, Min Zhang, Ling-Xiao Liao, et al.
Nature Nanotechnology|February 27, 2019
Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerJiangsheng Xu, Yunhua Liu, Yujing Li, et al.
Journal of the American Chemical Society|April 10, 2024
Silver Surface-Assisted Dehydrobrominative Cross-Coupling between Identical Aryl BromidesZhen-Yu Yi, Zi-Cong Wang, Ruo-Ning Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2023
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemiaSanthosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, et al.
Elife|June 13, 2024
Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's diseaseDoo Eun Choi, Jun Wan Shin, Sophia Zeng, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
CDH3 as a Novel Therapeutic Target in Basal-like Double-Negative Prostate CancerGuoqiang Liu, Shiyu Wang, Loan Duong, et al.
Nature Nanotechnology|January 19, 2020
Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerJiangsheng Xu, Yunhua Liu, Yujing Li, et al.
Frontiers in Oncology|October 22, 2021
β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 HyperactivationWenxiu Zhao, Lingxiang Jiang, Ting Fang, et al.
Drug Design, Development and Therapy|October 18, 2023
The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and FibrosisMenglong Wang, Wei Pan, Cheng Wei, et al.
Pageof 145

Showing results (1171-1180 of 1,448) with videos related to

Sort By:
Pageof 145
Circulation. Cardiovascular Imaging|September 11, 2019
Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary HypertensionKhodr Tello, Jun Wan, Antonia Dalmer, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|February 12, 2021
Long non-coding RNA PCA3 inhibits lipid accumulation and atherosclerosis through the miR-140-5p/RFX7/ABCA1 axisZhen-Wang Zhao, Min Zhang, Ling-Xiao Liao, et al.
Nature Nanotechnology|February 27, 2019
Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerJiangsheng Xu, Yunhua Liu, Yujing Li, et al.
Journal of the American Chemical Society|April 10, 2024
Silver Surface-Assisted Dehydrobrominative Cross-Coupling between Identical Aryl BromidesZhen-Yu Yi, Zi-Cong Wang, Ruo-Ning Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2023
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemiaSanthosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, et al.
Elife|June 13, 2024
Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's diseaseDoo Eun Choi, Jun Wan Shin, Sophia Zeng, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
CDH3 as a Novel Therapeutic Target in Basal-like Double-Negative Prostate CancerGuoqiang Liu, Shiyu Wang, Loan Duong, et al.
Nature Nanotechnology|January 19, 2020
Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerJiangsheng Xu, Yunhua Liu, Yujing Li, et al.
Frontiers in Oncology|October 22, 2021
β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 HyperactivationWenxiu Zhao, Lingxiang Jiang, Ting Fang, et al.
Drug Design, Development and Therapy|October 18, 2023
The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and FibrosisMenglong Wang, Wei Pan, Cheng Wei, et al.
Pageof 145